Vigil Neuroscience Ownership | Who Owns Vigil Neuroscience?
Vigil Neuroscience Ownership Summary
Vigil Neuroscience is owned by 70.20% institutional investors, 18.16% insiders, and 11.64% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 12.26% of VIGL shares. abrdn Life Sciences Investors is the top mutual fund, with 3.03% of its assets in Vigil Neuroscience shares.
VIGL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Vigil Neuroscience | 70.20% | 18.16% | 11.64% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Atlas venture life science advisors | 5.84M | 12.26% | $46.40M |
Northpond ventures | 4.21M | 10.57% | $16.86M |
Glazer capital | 3.01M | 6.33% | $23.95M |
Artal group | 1.83M | 4.59% | $7.31M |
Citadel advisors | 1.44M | 3.62% | $5.77M |
683 capital management | 1.26M | 2.65% | $10.03M |
Gabelli funds | 1.19M | 2.50% | $9.46M |
Vanguard group | 975.47K | 2.40% | $1.66M |
Alpine associates management | 1.09M | 2.30% | $8.70M |
Highbridge capital management | 865.04K | 1.82% | $6.88M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Northpond ventures | 4.21M | 30.50% | $16.86M |
Atlas venture life science advisors | 5.84M | 7.01% | $46.40M |
Chicago capital management | 482.77K | 2.82% | $3.84M |
Pivotal bioventure partners investment advisor | 560.60K | 2.76% | $4.46M |
Gabelli & co investment advisers | 864.95K | 1.06% | $6.88M |
Glazer capital | 3.01M | 0.86% | $23.95M |
Black maple capital management lp | 215.99K | 0.77% | $1.72M |
683 capital management | 1.26M | 0.66% | $10.03M |
Alpine associates management | 1.09M | 0.46% | $8.70M |
Irenic capital management lp | 371.32K | 0.44% | $2.95M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Glazer capital | 3.01M | 0.86% | 3.01M |
Gabelli funds | 1.19M | 0.07% | 1.19M |
Alpine associates management | 1.09M | 0.46% | 1.09M |
Highbridge capital management | 865.04K | 0.28% | 865.04K |
Gabelli & co investment advisers | 864.95K | 1.06% | 864.95K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bvf inc/il | - | - | -4.01M |
Abrdn | - | - | -1.72M |
Sphera funds management | - | - | -1.60M |
Ensign peak advisors | - | - | -1.58M |
Siren | 411.19K | 0.17% | -1.56M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Glazer capital | 3.01M | 0.86% | 3.01M | $23.95M |
Gabelli funds | 1.19M | 0.07% | 1.19M | $9.46M |
Alpine associates management | 1.09M | 0.46% | 1.09M | $8.70M |
Highbridge capital management | 865.04K | 0.28% | 865.04K | $6.88M |
Gabelli & co investment advisers | 864.95K | 1.06% | 864.95K | $6.88M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -2.00 |
Nisa investment advisors | -45.00 |
New york state common retirement fund | -140.00 |
Coldstream capital management | -187.00 |
Federated hermes | -313.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 77 | 60.42% | 33,428,709 | 78.58% | 70 | 4.25% | 63 | 200.00% | 9 | -57.14% |
Mar 31, 2025 | 50 | -1.96% | 25,028,008 | 10.68% | 54 | 1.75% | 21 | -32.26% | 21 | 90.91% |
Dec 31, 2024 | 51 | -1.92% | 22,613,677 | -18.44% | 55 | 1.19% | 31 | 34.78% | 11 | -38.89% |
Sep 30, 2024 | 52 | -7.14% | 27,725,211 | 6.11% | 68 | 1.59% | 24 | -22.58% | 18 | 5.88% |
Jun 30, 2024 | 56 | 7.69% | 26,129,244 | -1.47% | 65 | 1.40% | 31 | 55.00% | 17 | 13.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
abrdn Life Sciences Investors | 1.41M | 3.03% | -395.92K |
Vanguard Total Stock Mkt Idx Inv | 770.91K | 1.62% | -17.03K |
GAMCO Intl SICAV Merger Arbtrg I (USD) | 371.74K | 0.80% | 371.74K |
Vanguard Institutional Extnd Mkt Idx Tr | 288.74K | 0.61% | -144.09K |
Carmignac Pf Merger Arb Plus I EUR Acc | 241.75K | 0.51% | 241.75K |
BlackRock Health Sciences Term Trust | 225.25K | 0.48% | - |
MEDICAL BioHealth EUR Acc | 202.97K | 0.43% | -316.00K |
GA-Courtenay Special Situations M GBP | 180.00K | 0.38% | 180.00K |
Fidelity NorthStar Sr F | 160.29K | 0.34% | 160.29K |
Fidelity Extended Market Index | 143.91K | 0.31% | 29.00K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 19, 2024 | Budd Haeberlein Samantha L. | - | Buy | $20.52K |
Dec 19, 2024 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $8.40K |
Dec 18, 2024 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $8.35K |
Dec 05, 2024 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $11.70K |
Nov 20, 2023 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $15.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | 4 | - |
2024 Q2 | - | - |
VIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools